Synopsis of recent research by authors named "Roma Sehmi"
- Roma Sehmi's recent research primarily focuses on the therapeutic effects of benralizumab in various allergic conditions, including atopic dermatitis and asthma, highlighting its ability to deplete eosinophils and mitigate inflammation in these patients.
- The studies encompassed a range of methodologies, from randomized, double-blind clinical trials to systematic reviews, showcasing innovations in targeted biologic treatments and the immune response dynamics in conditions such as COVID-19 and allergic bronchopulmonary aspergillosis.
- Sehmi's work also investigates the role of innate immune cells in asthma and the intricate mechanisms of cytokine production, emphasizing novel findings related to neuromedin U and its effects on group 2 innate lymphoid cells, which are critical in severe asthma pathogenesis.